CliniGA CRO

CliniGA CRO Blog

Separating trial completion, site close-out and product closure in Türkiye

Coordinate distinct completion records, site close-out evidence, product reconciliation and remaining participant obligations.

Cover image for: Separating trial completion, site close-out and product closure in Türkiye
Photo: Department for Science, Innovation and Technology · License: CC BY 2.0 · Cropped and resized.
Published
Updated
Sources checked

Last participant last visit, site close-out and a regulatory completion notice are different milestones. Treating them as one date can obscure unfinished safety follow-up or product reconciliation in a Türkiye study.

Define each closing milestone

TİTCK provides completion notification information and separate product closure resources. Use the applicable current guidance to establish each submission and its triggering event. Avoid a universal deadline calculated from a convenient database date; the relevant event and reporting requirement need explicit confirmation.

Create a closure dependency map

Our recommended dependency map links participant care, data queries, site close-out, product accountability, submission records and archive transfer. Each stream has its own owner and completion evidence. A site may stop recruitment while still caring for participants, and a finished visit schedule may leave unresolved safety information.

Check the final handover

  • Agree the protocol-defined completion event and reconcile country and global milestones.
  • Confirm outstanding participant follow-up, queries and safety reconciliation responsibilities.
  • Reconcile received, used, returned and destroyed product before the closure package is finalized.
  • Archive applicable notifications, receipts and signed handover records with the study file.

Keep residual obligations visible

A closure meeting should leave a short residual-obligations register, not merely a green dashboard. Identify who answers later authority questions, maintains contact details and retrieves records. Retain evidence that receiving archive and safety teams have accepted their ongoing duties.

Frequently asked questions

Does site close-out end all sponsor responsibilities?
No. Reporting, follow-up and record responsibilities may remain after the operational visit.
Can product closure be inferred from zero stock?
No. Reconcile the full quantity history and the applicable closure documentation.

Sources

  1. TİTCK — Completion notification module instructions
  2. TİTCK — Clinical research application guidance and module notes